Bingley PJ - Search Results

1

Evidence that HLA class I and II associations with type 1 diabetes, autoantibodies to GAD and autoantibodies to IA-2, are distinct.

Howson JM, Stevens H, Smyth DJ, Walker NM, Chandler KA, Bingley PJ, Todd JA. Howson JM, et al. Among authors: bingley pj. Diabetes. 2011 Oct;60(10):2635-44. doi: 10.2337/db11-0131. Epub 2011 Aug 10. Diabetes. 2011. PMID: 21831970 Free PMC article.

2

Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives.

Bingley PJ, Christie MR, Bonifacio E, Bonfanti R, Shattock M, Fonte MT, Bottazzo GF, Gale EA. Bingley PJ, et al. Diabetes. 1994 Nov;43(11):1304-10. doi: 10.2337/diab.43.11.1304. Diabetes. 1994. PMID: 7926304

3

Interactions of age, islet cell antibodies, insulin autoantibodies, and first-phase insulin response in predicting risk of progression to IDDM in ICA+ relatives: the ICARUS data set. Islet Cell Antibody Register Users Study.

Bingley PJ. Bingley PJ. Diabetes. 1996 Dec;45(12):1720-8. doi: 10.2337/diab.45.12.1720. Diabetes. 1996. PMID: 8922357

4

Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop.

Verge CF, Stenger D, Bonifacio E, Colman PG, Pilcher C, Bingley PJ, Eisenbarth GS. Verge CF, et al. Among authors: bingley pj. Diabetes. 1998 Dec;47(12):1857-66. doi: 10.2337/diabetes.47.12.1857. Diabetes. 1998. PMID: 9836516

5

Capillary whole blood measurement of islet autoantibodies.

Bazzigaluppi E, Bonfanti R, Bingley PJ, Bosi E, Bonifacio E. Bazzigaluppi E, et al. Among authors: bingley pj. Diabetes Care. 1999 Feb;22(2):275-9. doi: 10.2337/diacare.22.2.275. Diabetes Care. 1999. PMID: 10333945

6

Optimized autoantibody-based risk assessment in family members. Implications for future intervention trials.

Bingley PJ, Williams AJ, Gale EA. Bingley PJ, et al. Diabetes Care. 1999 Nov;22(11):1796-801. doi: 10.2337/diacare.22.11.1796. Diabetes Care. 1999. PMID: 10546010

7

Progression to diabetes in relatives with islet autoantibodies. Is it inevitable?

Gardner SG, Gale EA, Williams AJ, Gillespie KM, Lawrence KE, Bottazzo GF, Bingley PJ. Gardner SG, et al. Among authors: bingley pj. Diabetes Care. 1999 Dec;22(12):2049-54. doi: 10.2337/diacare.22.12.2049. Diabetes Care. 1999. PMID: 10587841

8

HLA class II typing of whole genome amplified mouth swab DNA.

Gillespie KM, Valovin SJ, Saunby J, Hunter KM, Savage DA, Middleton D, Todd JA, Bingley PJ, Gale EA. Gillespie KM, et al. Among authors: bingley pj. Tissue Antigens. 2000 Dec;56(6):530-8. doi: 10.1034/j.1399-0039.2000.560607.x. Tissue Antigens. 2000. PMID: 11169243

9

Proposed guidelines on screening for risk of type 1 diabetes.

Bingley PJ, Bonifacio E, Ziegler AG, Schatz DA, Atkinson MA, Eisenbarth GS; Immunology of Diabetes Society. Bingley PJ, et al. Diabetes Care. 2001 Feb;24(2):398. doi: 10.2337/diacare.24.2.398. Diabetes Care. 2001. PMID: 11213898 No abstract available.

10

The high prevalence of autoantibodies to tissue transglutaminase in first-degree relatives of patients with type 1 diabetes is not associated with islet autoimmunity.

Williams AJ, Norcross AJ, Lock RJ, Unsworth DJ, Gale EA, Bingley PJ. Williams AJ, et al. Among authors: bingley pj. Diabetes Care. 2001 Mar;24(3):504-9. doi: 10.2337/diacare.24.3.504. Diabetes Care. 2001. PMID: 11289476

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

186 results

Search Page